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LITERATURE REVIEW
The monocyte-macrophage system is a network of specialized
phagocytic cells, including peripheral blood monocytes, Kupffer cells
of the liver, microglial cells of the brain, macrophages of lymph
node and spleen, alveolar macrophages, other fixed tissue
macrophages and fluid phase macrophages (13). Macrophages playa
variety of roles in both the afferent and efferent limbs of the
immune response. Macrophages are involved in the initiation of
immune reactions as antigen-presenting cells, and in the effector
phase as inflammatory, tumoricidal, microbiocidal and regulatory
cells (11 ,64). There is evidence that peripheral blood monocytes
originate from bone marrow precursor cells and that tissue
macrophages are derived from circulating monocytes (22,48).
Because macrophages perform many functions, investigators
hypothesized that it was unlikely for a single, homogeneous
precursor cell population to be responsible for such functional
diversity (49). Indeed, evidence suggests that monocyte
subpopulations exist which may represent different activation
states, different stages of maturation, or distinct, stable subsets
(12,21 ).
Evidence For Macrophage Heterogeneity
The development of monoclonal antibodies to human T
lymphocyte surface antigens allowed for the characterization of T
lymphocyte subsets (33). The same approach has been used to study
1
2antigenic markers on the surface of tissue and fluid phase
macrophages and has revealed surface membrane heterogeneity
among macrophages from different anatomical sites (6).
Cell surface antigens have been identified that are present
virtually exclusively on human peripheral blood monocytes (5,29),
tissue or fluid phase macrophages (1-3,6,57,58,67). In addition, cell
surface antigens have been identified that are present on peripheral
blood monocytes and tissue or fluid macrophages (29,63). The PHM3
monoclonal antibody detects a surface antigen that is expressed by
most peripheral blood monocytes but is expressed only at very low
levels on peritoneal macrophages and Kupffer cells (5). Likewise,
FMC17 and FMC34 recognize antigens present on circulating
monocytes that are lost or markedly decreased in quantity when
monocytes enter inflammatory sites (29). On the other hand, Biondi
et al. described anti-PAM1 and anti-BMM1, two monoclonal
antibodies specific for lung macrophages and breast milk
macrophages, respectively (6). Andreesen et al. described a series
of monoclonal reagants that recognize MAX antigens which are found
only on exudate macrophages residing in serous cavities (1-3), while
Dimitriu-Bona et al. reported on M0P-15 and M0P-7, which
demonstrate moderate and weak immunofluorescent staining,
respectively, for the majority of circulating monocytes but intense
staining for fluid phase macrophages (14). Moreover, Zwadlo et al.
have shown that the monoclonal antibody 27F9 labels most resident
tissue macrophages but not circulating monocytes (67). However,
PHM2, FMC32, FMC33, and 63D3 persist through all stages of
3mononuclear phagocyte differentiation, including end-stage
granuloma formation (29,63).
Evidence For Monocyte Functional Heterogeneity
In the last ten years, numerous studies have revealed
functional heterogeneity of human peripheral blood monocytes and
the presence of subpopulations which may represent both
functionally and morphologically different subsets (16,
19,21 ,25,32,39,44,45,47,56,61 ,62,66). Countercurrent centrifugal
elutriation, Percoll and bovine serum albumin (BSA) density
gradients, and adherence have been used to physically separate
monocytes into subpopulations.
Monocyte subpopulations differing in' Fe receptor activity have
been isolated. Norris and coworkers, using countercurrent
centrifugal elutriation to isolate monocyte subpopulations,
demonstrated that peripheral blood monocytes could' be divided into
two subsets, which they designated "small" and "large" (45). Both
subsets were phagocytic, glass adherent and nonspecific esterase
positive. However, the small monocytes were deficient in Fe
receptor-mediated activity, while the large monocytes were not.
This study was flawed, however, since it appears that there was
significant lymphocyte contamination of the small monocyte
fraction. Melewicz and Spiegelberg, using adherence to isolate
monocytes from mononuclear cell preparations, presented evidence
that a subpopulation of monocytes from healthy human donors
4presumably mediated phagocytosis and lysis of IgE-coated target
cells through their Fe receptors for Ig E (39).
Functional heterogeneity with respect to colony-stimulating
factor (CSF) release has been shown. Yasaka et al. isolated two
monocyte subpopulations by countercurrent centrifugal elutriation
(66). The two subpopulations exhibited similar functional
properties; however, the larger subpopulation was responsible for
greater CSF release. Likewise, Tice et aI., upon separating
monocytes on Percoll gradients, found significantly greater CSF
activity in the more dense monocyte fractions than in the least
dense fraction (56). Because monocytes were isolated from
mononuclear cells by one hour adherence in this study, it is possible
that differential activation of the isolated subsets may have
occurred, generating artifactual subpopulations.
Monocyte subpopulations differing in hydrogen peroxide (H202),
myeloperoxidase and tumoricidal activity have been isolated. Turpin
et al. separated monocytes into subpopulations by countercurrent
centrifugal elutriation and showed that the large monocytes were
responsible for greater H202 production at day one of culture, while
by day three, small monocytes were the major producers of H2 0 2
(62). Yasaka et al. found higher myeloperoxidase activity in the
larger monocyte fraction isolated by countercurrent centrifugal
elutriation (66). Finally, Normann and Weiner separated monocytes
by elutriation and noted that only the small monocytes appeared
responsible for tumoricidal activity (44).
Differential synthesis of prostaglandins by monocyte
subpopulations has been reported by several invesigators. Goldyne
5et al. sedimented human peripheral blood monocytes isolated by
adherence through a five step discontinuous BSA density gradient
and found significant differences in prostaglandin E2 (PGE2)
synthesis among the subpopulations (25). However, in this study the
stimulus used for monocyte activation was not mentioned. Picker et
al., when fractionating mononuclear cell suspensions on
discontinuous BSA gradients, showed that a population of low
density monocytes produced the majority of PGE (47). Finally,
Treves et al. isolated monocytes by adherence to plastic and
reported that the loosely adherent monocytes secreted more PGE2
than the strongly adherent ones (61).
Differential interleukin-1 (IL-1) elaboration by density-
defined human monocyte subpopulations has been noted. Elias et al.
divided monocytes into subpopulations using discontinuous Percoll
density gradients (16). The denser monocytes produced more IL-1
than the less dense cells. Khansari et .al. separated human peripheral
blood monocytes on discontinuous BSA gradients and reported
production of the majority of PGE2 and IL-1 by two different
monocyte fractions (32). Finally, Treves found that loosely adherent
monocytes secreted higher amounts of IL-1 than the strongly
adherent monocytes (61).
Nichols et al. demonstrated differential specific activities of
PG E2 and thromboxane 82 (Tx82) released by lipopolysaccharide
(LPS)-treated human monocytes over a 24 hour period, which
suggests the presence of at least two subpopulations of monocytes
with distinct secretory responses (42). Because PGE2 and TxB2 are
derived from a common precursor, arachidonic acid, in the
6cyclooxygenase pathway, one would have expected identical specific
activities for TxB2 and PGE2 if LPS-treated human monocytes were
labeled with arachidonic acid of uniform specific activity. In this
study, monocytes were prelabeled for two hours with 0.1 JlCi/ml of
3H-arachidonic acid and 14C-arachidonic acid. Cells were then
washed to remove unincorporated label and treated continuously
with 10 Jl9/ml Salmonella typhimurium LPS plus 0.1 JlCi/ml 14C_
arachidonic acid. Parallel unlabeled cultures were treated with LPS
to determine immunoreactive PGE2 and TxB2 levels in culture
supernatants. The specific activities of 3H- and 14C_ PG E2 during the
0-2 hour interval were similar and approximately three times higher
than the corresponding TxB2 specific activities. By 24 hours, the
specific activities of 3H-PGE2 and 3H-TxB2 converged to a lower
level while the 14C_TxB2 specific activity increased to almost equal
that of 14C-PGE2.
In addition, this study attempted to examine whether
differences in PGE2 and TxB2 specific activities could be attributed
to the selective conversion of arachidonic acid from specific
sources, either free exogenous arachidonic acid or arachidonic acid
incorporated in membrane phospholipids. Monocytes were pulse-
labeled for two hours with both 0.1 JlCi/ml 3H- and 14C-labeled
arachidonic acid. Cells were then washed and treated continuously
with medium containing LPS and either 14C-arachidonic acid alone,
3H-arachidonic acid alone, or both 14C-arachidonic acid and 3H-
arachidonic acid' at 0.1 J,lCi/ml. 3H/14C ratios for radiolabeled PGE2
and TxB2 in culture supernatants were intermediate between 3H/14C
ratios for free arachidonic acid and the major phospholipids
7(phosphatidylinositol, phosphatidylcholine and phosphatidyl-
ethanolamine) during the 0-2 and 2-8 hour time intervals regardless
of continuous label used. These experiments showed that both
exogenous and endogenous sources of arachidonic acid serve as
sources of TxB2 and PGE2. Therefore, the differences in metabolic
specific activities between PGE2 and TxB2 cannot be accounted for
by selective metabolism of either source of arachidonic acid (42).
Even though there is abundant evidence in the literature which
suggests that human peripheral blood monocytes may consist of
functionally different subsets, conclusive evidence is lacking for
several reasons. First, several different techniques were used to
isolate human peripheral blood monocytes, thereby making
interpretation of the literature difficult. In a number of studies,
adherence was used to enrich mononuclear cell preparations.
Monocytes obtained by adherence are often activated by this
isolation procedure. Second, detection of cell surface markers with
monoclonal antibodies was not used to rule out the presence of
other contaminating peripheral blood elements, particularly
lymphocytes, in monocyte cultures. "Pure" monocyte preparations
isolated by adherence often contain plastic adherent, activated
lymphocytes or phagocytic granulocytes. Third, culture conditions
and stimuli used to activate the monocytes were not uniform.
Furthermore, no mention was made of monocyte secretory product
release from unstimulated monocyte cultures in a number of these
studies. Finally, DNA assays to correct for cell number were not
performed in several of these investigations.
8Evidence For Monocyte Phenotypic Heterogeneity
Monoclonal antibodies have been developed in an attempt to
define distinct monocyte populations. Breard et al. used OKM1
(CD11 b), a monoclonal antibody to the C3bi receptor, to define two
populations of monocytes that differed with respect to cell size,
adherence properties and surface la antigens (9,53). Shen et al. used
OKM1 and OKM5 to isolate two functionally distinct human monocyte
subsets (54). These investigators identified a rosette negative,
OKM 1-, OKM5+ subset that triggered the autologous mixed lymphocyte
reaction, and a rosette negative, OKM1 +, OKMS- subset that could
only minimally trigger this reaction (54). Because OKM1 is
expressed on greater than 90% of peripheral blood monocytes and
OKM5 is expressed on 75% of peripheral blood monocytes, the results
of this study have been questioned (36). Furthermore, because 1)
OKM 1 is expressed by 30% of peripheral blood lymphocytes and most
natural killer (NK) cells, neutrophils and eosinophils, and 2) OKM5 is
also reactive with platelets, the presence of other peripheral blood
elements in monocyte isolates could have had a great impact on the
observed results. Finally, Talle et al. demonstrated reactions of
OKM3 and OKM6 with subsets of adherent monocytes (55).
Unfortunately, these antibodies have never become commercially
available and no additional reports on their characteristics have
appeared in the literature.
Raff et at. have reported that cells positive for Mac-120 and
HLA-DR can function in the genetically restricted presentation of
antigen to T cells, while cells negative for Mac-120 and positive for
9HLA-DR cannot (50). In addition, this group demonstrated that Mac-
120 positive cells were the most effective stimulators of the
autologous mixed lymphocyte reaction. However, the staining
pattern of Mac-120 does not reveal the prese.nce of subpopulations
(26), and the monoclonal antibody and clone responsible for its
production are no longer available. This antigen is not generally
accepted as a monocyte subpopulation marker.
Several groups over the last few years have identified cell
surface antigens that are expressed only in response to monocyte
activation by either LPS, phorbol esters, or muramyl dipeptide, a
structurally defined fragment of bacterial peptidoglycan (18,30,59).
Although these monoclonal antibodies have not yet been reported to
identify a subset that has 9.reater functional activity, these
antibodies do serve as excellent markers of monocyte activation.
Todd et al. produced a monoclonal antibody, anti-M03e, whose
expression is increased by LPS (59). A more detailed description of
this monoclonal antibody will follow. Furthermore, Ewan et al.
developed a monoclonal antibody, A1-3, which binds selectively to
LPS-stimulated human peripheral blood monocytes and is associated
with procoagulant activity (18). In an immunohistochemical study
using this antibody, Hancock et al. found restriction of A1-3 binding
to monocytes in inflammatory tissues and not in normal tissues
(30). Similarly, Zwadlo et al. produced a monoclonal antibody,
27E10, that detects a surface antigen found only on macrophages in
inflammatory tissues and not in normal tissues, and detects an
antigen that is present on only 20% of peripheral blood monocytes
(68). 27E10 antigen density is increased by stimulating monocytes
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in culture with y-interferon (IFN), 12-0-tetradecanoyl-phorbol-13-
acetate (TPA) and LPS. Interestingly, Zwadlo et al. have also
described a surface antigen, RM3/1, that is down-regulated by LPS,
y-IFN, and TPA and appears to be associated with the healing phase
of the inflammatory process (69).
At this time, however, no monoclonal antibody is uniformly
accepted as a marker of a distinct monocyte subpopulation.
Characteristics of Mo3e and Leu-M3
Freshly isolated adherent human monocytes express barely
detectable amounts of the M03e antigen on their cell surfaces (59).
However, following an 18-24 hour incubation at 37°e in RPMI 1640
medium containing E. coli LPS, monocytes demonstrate a significant
increase in surface M03e expressi.on (59). On the other hand,
monocytes cultured for the same duration in LPS-free medium
express surface M03e levels comparable to those observed for
freshly isolated cells (59). In addition, muramyl dipeptide, phorbol
myristate acetate (PMA) and other biologically active phorbol
compounds· cause a dose-dependent increase in surface M03e
expression boy monocytes cultured for 18-72 hours in medium
containing these agents (59). M03e has been termed an activation-
associated antigen because it is selectively expressed by activated
macrophages and monocytes. However, y-IFN has no effect on M03e
expression. The Mo3e antigen is specific for monocytes and
macrophages and it is identified by an IgM monoclonal antibody,
anti-M03e (35,59).
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The Mo3e antigen is a protein determinant and is, therefore, a
protease-sensitive antigen (60). Mo3e expression is temperature
dependent since incubation of monocytes at 4°C prevents its
expression, which suggests that Mo3e expression depends on active
cellular metabolism. Furthermore, protein synthesis inhibitors such
as cycloheximide and puromycin block Mo3e expression by LPS-
stimulated monocytes. Finally, pre-treatment of monocytes with
the anti-M03e antibody blocks their response to migration inhibitory
factor (MIF). This effect is specific since other IgM monoclonal
reagants fail to block MIF activity (35). These data suggest that
Mo3e is the MIF receptor (35).
The Leu-M3 antigen (CD 14) was first described by Dimitriu-
Bona et al. (14). The M~P-9 clone is responsible for the IgG2 b
monoclonal antibody that recognizes Leu-M3, a pan-monocytic
marker that is present on 70-900/0 of human peripheral blood
monocytes, 77-900/0 of pleural or peritoneal fluid phagocytic cells,
and 86-92% of synovial mononuclear phagocytes (Becton-Dickinson
technical bulletin). The Leu-M3 antigen is found at high densities on
monocyte and macrophage cell surfaces. Leu-M3 is present at very
low antigen densities on a minimal fraction of peripheral blood
granulocytes (14), and does not react with lymphocytes,
erythrocytes, or platelets.
RATIONALE AND SPECIFIC OBJECTIVES
The independent synthesis of TxB2 and PGE2 by counterflow-
isolated human monocytes suggests the presence of monocyte
subsets with different secretory responses (42). Furthermore,
although inconclusive, there are numerous papers in the literature
which suggest that monocyte subpopulations exist and differ with
respect to PGE2 and IL-1 p release, Fe receptor expression, colony-
stimulating activity, H202 production and tumoricidal capacity
(16,25,32,44,45,47,56,61 ,62,66).
It was reported that peripheral blood monocytes from patients
with severe periodontitis secreted two to three times more PGE2 in
response to LPS from Bacteroides gingiva/is, B. intermedius,
Actinobacillus actinomycetemcomitans or Salmonella typhimurium
than peripheral blood monocytes of sex-, age-, and plaque-matched
patients without attachment loss (24). However, monocyte
secretion of IL-1 J3 did not significantly differ between the two
patient groups. A PGE2 hypersecretory response has also been
observed in peripheral blood monoctyes isolated from patients with
Hodgkin's disease when compared to monocytes isolated from
healthy control patients (17,27).
Because monocyte subpopulations that differ with respect to
P G E 2 release may exist, it is tempting to speculate that the
hypersecretory responses observed in severe periodontitis and
Hodgkin's disease patients may be a result of hypersecretion of a
distinct subset. In addition, the differential specific activities of
TxB2 and PGE2 may be a reflection of different secretory responses
12
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from distinct monocyte subpopulations. It is the purpose of this
thesis to assess PGE2, TxB2 and IL-1 ~ release from LPS-stimulated
monocyte subsets generated by either countercurrent centrifugal
elutriation or discontinuous Percoll density centrifugation, the
major methods that have been used in previous investigations to
fractionate peripheral blood monocytes into subpopulations.
However, no study in the literature has evaluated monocyte
subpopulations generated by both methods and no investigation has
combined the two techniques to generate monocyte subsets.
Counterflow centrifugal elutriation was selected to enrich
mononuclear cell preparations for monocytes because elutriation, as
opposed to adherence, does not activate monocytes and allows for
rapid isolation of peripheral blood monocytes in high purity
(20,28,37,52). In addition, Mo3e expression was examined to
determine if differences in cell surface expression of this
activation antigen could be correlated with differences in functional
responses between subpopulations. M03e expression was examined
relative to expression of Leu-M3, the pan-monocytic marker which
served as a positive control.
ABSTRACT
The purpose of this investigation was to separate
counterflow-isolated human peripheral blood moncytes into
subpopulations by either discontinuous Percoll density gradients or
countercurrent centrifugal elutriation and to assess PGE2, TxB2 and
IL-1 f3 release by each of the subsets in response to Salmonella
typhimurium LPS. In addition, surface antigen expression of Leu-
M3, a pan monocytic marker, and M03e, an LPS-associated antigen,
was examined to determine if M03e expression could be correlated
with differences in functional responses. PGE2, TxB2 and IL-1(3
levels in culture supernatants were determined by
radioimmunoassay.
After DNA correction, PGE2, TxB2 and IL-1 J3 release did not
differ significantly between LPS-stimulated monocyte fractions
isolated by either countercurrent centrifugal elutriation or Percoll
density centrifugation. In addition, although the specific activities
of PGE2 and TxB2 differed throughout the 24 hour LPS treatment
period, the specific activities did not differ between counterflow-
isolated subpopulations. Furthermore, Leu-M3 and M03e antigen
expression on the monocyte cell surface did not significantly differ
at 0, 8, or 24 hours between subpopulations isolated by either
separation technique. These data suggest that human peripheral
blood monocyte subpopulations separated by physical means are not
heterogeneous with respect to PGE2, TxB2 and IL-1(3 release as has
been previously reported and that the different specific activities of
TxB2 and PGE2 may be due to independent metabolism within a single
14
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population of cells rather than by different monocyte
subpopulations.
INTRODUCTION
Numerous investigators in the past decade have physically
separated human peripheral blood monocytes into subpopulations on
the basis of density or size in an attempt to determine whether
monocyte subsets with different functional capabilities can be
isolated. Counterflow centrifugal elutriation has been used to
fractionate monocytes into subpopulations that differ in Fc receptor
activity (45), CSF release and myeloperoxidase activity (66), H202
production (62) and tumoricidal activity (44). Centrifugation
through discontinuous Percoll and BSA density gradients has yielded
fractions exhibiting differences in colony-stimulating activity (56),
PGE release (4,25,32,47) and IL-1 production (16,32). Finally,
adherence to plastic or glass has been used to separate monocytes
into subpopulations and Treves et al. found that loosely adherent
monocytes secreted higher amounts of IL-1 than strongly adherent
monocytes (61). However, a number of these studies have been
criticized because either significant lymphocyte contamination of
monocyte cultures existed, activation of monocytes by the isolation
technique occurred or DNA assays were not performed to correct for
cell number.
The capacity of unfractionated counterflow-isolated human
peripheral blood monocytes to independently synthesize TxB2 and
PG E 2 when stimulated with bacterial LPS has been previously
demonstrated (42). Independent metabolism was confirmed by
showing that TxB2 and PGE2 had different specific activities within
each time interval during a 24 hour culture period. These data
16
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suggest that distinct monocyte subpopulations with different
secretory responses may exist within an unfractionated isolate of
cells. It is uncertain whether these differential specific activities
are due to the existence of physically separable monocyte subsets.
Indeed, such monocyte functional heterogeneity may reflect the
existence of discrete cell lineages, subsets representing different
activation states or maturation states (21) or distinct metabolic
processes within a single subset of cells.
Attempts have been made to define discrete monocyte
subpopulations using monoclonal antibodies (9,50,54,55). However,
conclusive evidence that subpopulations differ with respect to cell
surface antigen expression is lacking. Because elaboration of
inflammatory mediators by monocytes is dependent on activation of
these cells by LPS, Iymphokines, and other soluble factors, it was
important to identify activation-associated antigenic determinants
on the monocyte cell surface. .Monoclonal antibodies to LPS-
associated antigenic determinants are now available
(18,30,35,59,60) and may be important in identifying monocyte
subsets in different stages of activation. Todd et al. have
characterized the Mo3e antigenic determinant and have found that
freshly isolated monocytes express barely detectable amounts of
M03e on their cell surfaces (35,59). However, after a 24 hour
exposure to LPS, a significant increase in Mo3e expression is seen
relative to monocytes exposed to LPS-free medium.
It is the purpose of this present investigation to determine
whether physical separation of counterflow-isolated monocytes into
subpopulations by either discontinuous Percoll density gradients or
18
countercurrent centrifugal elutriation yields subpopulations with
distinct secretory responses. PGE2, TxB2 and IL-1 ~ release by LPS-
treated human monocytes were assessed. 11-1 ~ production was
investigated because 1) recent evidence suggests that the release of
IL-1 and PGE2 from monocytes is interrelated (34) and 2) 90% of the
IL-1 produced by LPS-stimulated human monocytes is IL-1 r3 (46). In
addition, Mo3e expression relative to the expression of Leu-M3, a
panmonocytic marker that served as a positive control, was
examined to assess whether differences in surface Mo3e expression
among the subpopulations could be correlated with differences in
functional responses.
MATERIALS AND METHODS
Materials
[3H]Arachidonic acid (sp. act., 100 Ci/mmole), [3H]TxB2, and
[3H] PG E2 were obtained from New England Nuclear (Boston, MA).
Ficoll, TxB2, PGE2, penicillin, streptomycin, 4' ,6-diamidino-2-
phenyl-indole (DAPI), FITC-conjugated goat anti-mouse IgG, FITC-
conjugated goat anti-mouse IgM, mouse IgG2b (MOPC 141), and mouse
IgM (TEPC 183) were obtained from Sigma Chemical Co. (St. Louis,
MO). Hypaque was obtained from Winthrop-Breon Laboratories
(NY,NY). Fluoresceinated beads were obtained from Flow Cytometry
Standards Corporation. Falcon plastic culture dishes (16 mm) were
obtained from Becton Dickinson Labware (Lincoln Park, NJ). Anti-
PGE 2 and Anti-TxB2 were obtained from Advanced Magnetics, Inc.
(Cambridge, MA) and fetal bovine serum was obtained from Hyclone
Laboratories (Logan, UT). The IL-1 f3 radioimmunoassay kit was
obtained from Cistron Biotechnology (Pine Brook, NJ). LPH-K thin-
layer plates (10x20 cm, precoated 200 f.1 m, silica gel G) were
purchased from Whatman International LTO. (Maidstone, England).
Bacterial lipopolysaccharide (Salmonella typhimurium) was obtained
from Difco Laboratories (Detroit, MI) and anti-Leu-5b (isotype
IgG2a), anti-Leu-12 (isotype IgG1) and anti-Leu-M3 (isotype IgG2b)
were obtained from Becton-Dickinson (Mountain View, CAl. Anti-
Mo3e (isotype IgM) was kindly provided by Dr. Robert Todd
(University of Michigan School of Medicine).
19
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Cell Isolation
Healthy random donors served as the sources of whole blood.
Subjects who had taken non-steroidal anti-inflammatory drugs
within the past week were excluded from the study. Citrated fresh
human blood, obtained by venipuncture, was layered over Ficoll-
Hypaque (1.077g/ml) (8) and sedimented at 400 x 9 (35 min., 10°C).
The mononuclear leukocyte fraction was collected, diluted and
washed in phosphate-buffered saline (PBS) containing 0.27 mM EDTA
(2x, 125 x g, 15 min., 10°C). This fraction was then subjected to
counterflow centrifugation (Beckman J2-21 centrifuge with JE-6B
rotor, Palo Alto, CA) to remove lymphocytes and platelets and yield
a highly enriched monocyte population, as previously described (51).
Elutriation was monitored by electronic counting «Coulter ZM-
counter, Coulter Electronics, Hialeah, Florida). Following
counterflow isolation, monocytes were pelleted in PBS containing
1010 autologous plasma (200 x g, 15 min., 10°C). Monocytes were
diluted in MCDB 104 medium (38) supplemented with 1% heat-
inactivated fetal bovine serum, 100 U/ml penicillin and 100 Jlg/m I
streptomycin, at a concentration of 106 cells/ml. Cells were plated
at 106 cells/well in 16 mm plastic wells. All incubations were
carried out at 37°C in a H20-saturated 5°1o C02 atmosphere. After
two hours, the medium was exchanged to remove any nonadherent
cells. At this time (time zero), 10 J.1g/ml of Salmonella typhimurium
LPS was added to half the wells. The other wells served as controls.
Medium was removed at 2, 8, 16 and 24 hours and was replaced with
fresh identical medium, and the supernatants were collected and
21
frozen. For experiments evaluating labeled metabolite release,
labeled arachidonic acid (0.1 JlCi/ml) was added to culture medium
either during the two hour adherence period only for pulse-labeled
cultures or during the two hour adherence period and the 24 hour LPS
treatment period for continuously-labeled cultures.
Incubation of Nonadherent Monocytes
Some media samples removed at 0, 2, 8, and 16 hours were
transferred to different culture wells and incubated until the 24
hour time point. These supernatants included nonadherent
monocytes (cells that had detached from the plates) and eicosanoids
produced by adherent cells during either the 0-2, 2-8 or 8-16 hour
time intervals. This additional incubation was designed to
determine the contribution of the nonadherent monocytes to overall
eicosanoid production.
Separation of Monocytes into Subpopulations
Fractionation of monocytes into subpopulations by elutriation
was achieved by varying the flow rate of the eluting buffer. After
the lymphocytes were eluted (mean=11 ml/min) the flow rate was
increased (mean=13.8 ml/min) until the small monocytes began to
elute. Once the small monocytes eluted, the superior portion of the
Sanderson chamber clarified and a new interface formed. At this
time, the flow rate was once again increased (mean=15 ml/min)
until the intermediate-sized monocytes began to elute. After these
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monocytes were collected, the remaining subpopulation was eluted
from the chamber by terminating centrifugation and flushing cells
from the rotor.
Fractionation of monocytes into subpopulations by
discontinuous density centrifugation was achieved by layering the
whole counterflow-isolated monocyte preparations over 10, 40, 45
and 50% Percoll (40, 45 and 50% Percoll corresponded to specific
gravities of 1.048, 1.056, and 1.063 g/ml, respectively). Attempts
were made to use density gradients of 35 and 55% Percoll; however,
too few cells were isolated from the interfaces with these
gradients. Monocyte subpopulations were aspirated from density
interfaces and pelleted in PBS to remove any remaining Percoll (2x,
200 x g, 15 min., 4°C) prior to placing them into culture.
Radioimmunoassay for PGE2, TxB2 and IL-1 J3
Levels of PGE2 and TxB2 in culture supernatants were
determined by radioimmunoassay using immunoadsorption to
dextran-coated charcoal. Levels of IL-1 ~ in culture supernatants
were determined by a radioimmunoassay which utilized a
polyethylene glycol second antibody to precipitate antibody-antigen
complexes (according to Cistron technical bulletin). All
determinations were carried out in d'uplicate and the average counts
for each pair were used to calculate PGE2, TxB2 and IL-1 J3 levels.
Regression coefficients for logit-Iog-transformed standard curves
~ were generally greater than 0.990.
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Labeled Arachidonic Acid Metabolite Extraction and
Separation
Arachidonic acid metabolites were extracted by adjustment of
the pH of culture supernatants to 3.5 with formic acid (70%)
followed by 3 3-ml washes with ethyl acetate. The combined
organic extracts were evaporated to dryness under vacuum and
stored at -20°C under nitrogen. Prior to thin-layer chromatography,
arachidonic acid (5 Jlg), PGE2 (5 f.1g) and TxB2 (5 f.1g) were added to
each sample and the contents were dried under a stream of nitrogen.
Individual samples were dissolved in 10 JlI of chloroform, mixed
vigorously, and spotted on silica gel G plates. Three additional
washes with 5 J.11 of chloroform were then performed and each wash
was plated immediately below the previous application. Plates were
then developed in one dimension with chloroform/methanol/acetic
acid/H 2 0 (90:8:1 :0.8, vol/vol) (65). After drying, the plates were
sprayed with H20 and the lipid spots were visualized. Arachidonic
acid metabolites were identified by co-migration with authentic
standards (Rf values were 0.80 for arachidonic acid, 0.512 for PGE2
and 0.40 for TxB2). The plates were then scraped and counts
determined.
Determination of Cell DNA Content
DNA content of adherent monocytes was determined at 0, 8 and
24 hours. Cells were treated with 0.5 ml of 5 mM NaOH and
sonicated briefly. After a one week incubation with NaOH to insure
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complete solubilization of the DNA, 100 ~I from each well was
assayed for DNA content by the 4' ,6-diamidino-2-phenyl-indole
fluorometric assay of Brunk et al. (10).
Flow Cytometric Analysis
One million monocytes isolated by counterflow centrifugal
elutriation or Percoll density centrifugation were placed into 12 X
75 mm siliconized glass test tubes. At either 0, 8, or 24 hours, the
suspension was centrifuged at 200 x 9 (5 min., 4°C). Saturating
doses of anti-Leu-M3 or anti-Mo3e were incubated with the pellet
(30 min., 4°C). Following two washes with PBS containing 5 mM
EDTA, the test cells were incubated with fluorescein-conjugated
goat anti-mouse immunoglobin of the appropriate isotype in antibody
excess (30 minutes, 4°C). The cells were then washed twice and
fixed in 100/0 buffered formalin. Prior to FACS analysis, cells were
centrifuged at 200 x g (5 min., 4°C) and suspended in 0.5 ml
Hematall. Ten thousand cells were examined by the FACS Analyzer
(Becton Dickinson, Mountain View, CAl and the channel number
representing the mean fluorescence intensity for each monoclonal
antibody was determined. The FACS Analyzer was calibrated each
day with fluoresceinated beads and the photomultiplier tube setting
was held constant for each experiment (400 V at maximum
resonance). Cell viability was evaluated by propidium iodide
exclusion and always exceeded 900/0. The extent of T and B
lymphocyte contamination was assessed with anti-Leu-5b and anti-
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Leu-12, respectively. The irrelevant monoclonal antibodies MOPC
141 (lgG2 b) and TEPC 183 (lgM) served as negative controls.
Data Analysis
Monocyte subpopulation means for PGE2, TxB2 and IL-1 p release
after DNA correction were compared by two-way ANOVA, with
treatment and fraction as the independent grouping-variables.
Monocyte subpopulation means for PGE2 and TxB2 specific activities
were compared by three-way ANOVA, with treatment, fraction and
time interval as the independent grouping-variables.
RESULTS
Distribution of Monocytes into Subpopulations
The mean distribution of monocytes isolated by discontinuous
Percoll density centrifugation was as follows: Fraction 1, harvested
from the density interface between 10 and 40% Percoll, contained
12% of the cells, while Fraction 2, harvested at the density
interface between 40 and 45% Percoll, contained 30% of the cells,
and Fraction 3, harvested at the density interface between 45 and
500/0 Percoll, contained 58% of the cells. The small, medium, and
large monocytes isolated by counterflow centrifugal elutriation
represented 27, 31, and 42%, respectively, of all recovered monocyte
isolates from six donors.
Coulter Profiles for Percoll-Isolated and Counterflow-
Isolated Monocyte Subpopulations
Percoll fractionation resulted in a substantial separation of
monocytes by relative cell size (Figure 1). The three subpopulations
isolated by elutriation differed markedly with respect to elution
properties, although their relative cell sizes were not as disparate
as monocyte fractions isolated by discontinuous Percoll gradients
(Figure 2).
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PG E2' TxB2 and IL-1~ Production by Percoll Fractions
In general, PGE2 release from fractions 2 and 3 was similar for
all time intervals (Figure 3). However, monocytes from fractions 2
and 3 secreted two to three times more PGE2 than monocytes from
fraction 1. Even though the same number of monocytes was plated
initially for all fractions, fraction 1 cultures retained only half as
much DNA per well as fractions 2 and 3 when compared at 8 and 24
hou rs (Table 1). Two-way ANOVA revealed no statistically
significant difference between fractions for PGE2 release, after DNA
correction.
Similarly, TxB2 release from fractions 2 and 3 was virtually
identical for all time intervals (Figure 4). However, cells from
fraction 1 secreted two to four times less TxB2 than cells from the
other two fractions. As for PGE2, TxB2 release after DNA correction
did not differ significantly between fractions when assessed by
two-way ANOVA (Table 1). Furthermore, all three fractions
exhibited the typical pattern of immunoreactive TxB2 release: peak
release during the 2-8 hour interval followed by a diminution in
T x B 2 release at the 16-24 hour interval to levels below those
observed for the 0-2 hour interval.
The vast majority of IL-1 f3 release occurred during the 2-8
hour interval. For this culture interval, 11-1 f3 release from fractions
2 and 3 was virtually identical. However, IL-1 f3 secretion by
Fraction 1 was two and one-half times less than IL-1 f3 secretion by
the other two fractions (Figure 5). After DNA correction, there was
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no statistically significant difference between fractions with
respect to IL-1J3 release (Table 1).
LPS-stimulated eicosanoid and IL-1 J3 release was always
significantly greater than the control release of these mediators for
all fractions for all time intervals.
PG E 2, TxB2 and IL-1 (3 Production by Elutriator Fractions
PG E 2 release did not differ between fractions for any of the
time intervals (Figure 6). In contrast to Percoll fractions, DNA
correction did not change this finding because the DNA remaining per
well at 24 hours was virtually identical for each fraction and for
both control and LPS':'stimulated cultures (Table 2). In addition,
TxB 2 and IL-1 (3 release did not differ between fractions for each
time interval (Figures 7 and 8). Likewise, DNA correction did not
alter these findings (Table 2).
Specific Activities of PGE2 and TxB2 for Pulse-Labeled
Elutriator Fractions
The specific activity of PGE2 for the 0-2 hour time interval
was three and a half times higher than for TxB2 (Figures 9 and 10).
The specific activities of both PGE2 and TxB2 converged to a lower
level by the 16-24 hour interval, although PGE2 still maintained a
specific activity that was twofold higher than that of TxB2 .
However, even though TxB2 and PGE2 had different specific activities
throughout the 24 hour time course, the specific activities of PGE2
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and TxB2 did not differ between fractions. Control values are not
included in Figures 9 and 10 because the amount of immunoreactive
eicosanoid produced by monocytes not exposed to LPS was so low
that specific activity calculations were not meaningful.
Specific Activities of PGE2 and TxB2 for Continuously-
Labeled Elutriator Fractions
PG E2 had a specific activity that was four and a quarter times
greater than that of TxB2 during the 0-2 hour interval (Figure 11 and
12). However, during the 24 hour time course, the specific activity
of PGE2 fell while the specific activity of TxB2 rose so that by the
16-24 hour time interval, the specific activity of TxB2 actually
overtook that of PGE2. Once again, the specific activities of both
TxB2 and PGE2 did not differ between fractions for any of the time
intervals.
Leu-M3 and M03e Expression on Percoll-Isolated Monocyte
Subpopulations
A representative dot plot and FACS profiles are illustrated in
Figure 13. M03e and Leu-M3 expression did not differ significantly
between fractions at 24 hours (Table 3). Mo3e expression on the cell
surface of the third Percoll fraction (the smallest monocytes) was
27% less than Mo3e expression on the cell surface of the first
Percoll fraction (the largest monocytes). Although the mean
fluorescence intensity for M03e was highest for the largest
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monocytes, it is likely that relative Mo3e antigen density is
comparable between fractions because the largest cells also have
the greatest cell surface area.
Leu-M3 and M03e Expression on Counterflow-Isolated
Monocyte SUbpopulations
Mo3e antigen expression on counter-flow-isolated monocyte
subpopulations was not detectable at time zero, since its mean
fluorescence intensity was virtually the same as the mean
fluorescence intensity of the negative control antibody. However,
after an 8 hour exposure to LPS, Mo3e antigen expression was
significantly increased (Table 4). A twofold increase in mean
fluorescence intensity was seen between 8 and 24 hours.
Nevertheless, no differences between fractions with respect to
mean fluorescence intensity were observed for any of the time
intervals. Greater than 800/0 of the monocytes were positive for the
Mo3e antigen at 8 hours and greater than 90% of the monocytes were
positive for Mo3e at 24 hours.
Leu-M3 antigen expression on counterflow-isolated monocyte
subpopulations also did not differ between fractions (Table 5). The
mean fluorescence intensity for the Leu-M3 antigen actually
diminished at 8 hours for all three fractions but increased by 24
hours to levels that were 68% higher than at 0 hours.
DISCUSSION
In contrast to previous reports (16,25,32,47,56,61), this study
demonstrated that Percoll-isolated and counterflow-isolated human
peripheral blood monocyte subpopulations do not differ with respect
to PGE2, TXB2 and IL-1 ~ release. It is likely that our findings differ
from those results previously reported for three reasons. First,
counterflow centrifugal elutriation, which allows rapid isolation of
human peripheral blood monocytes in high purity, was used rather
than adherence to enrich mononuclear cell preparations. Second,
indirect immunofluorescence confirmed negligible lymphocyte
contamination of our monocyte preparations Finally, DNA assays
w~re performed to correct for cell number. This paper also
represents the first report in the literature to examine relative
antigen expression of monocyte markers on different subpopulations;
Leu-M3 and Mo3e antigen expression did not differ between subsets
isolated by either Percoll density centrifugation or counterflow
centrifugal elutriation.
Monocyte purity was confirmed by showing that 70-900/0 of
counterflow-isolated monocytes expressed the Leu-M3 antigen and
that negligible numbers of cells expressed Leu-12 or Leu-5b.
Microscopic examination of cells using Wright's stain revealed the
absence of polymorphonuclear leukocytes and eosinophils in culture
wells. Minimal platelet contamination of the monocyte preparations
was observed by phase contrast microscopy. It has been
demonstrated that PGE2 and TxB2 release from monocytes incubated
with a tenfold excess of platelets is comparable in control and LPS-
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stimulated cultures (42). In addition, PGE2 and TxB2 release from
monocytes cultured with this excess of platelets is maximal during
the 8-16 hour time interval, rather than the 2-8 hour time interval.
Had there been substantial platelet contamination of the monocyte
cultures, this nonspecific elevation and different pattern of
eicosanoid release would have been observed (42).
The anti-PGE2 antibody demonstrates 100% cross-reactivity
with PGE1, 90/0 with 15-HETE, 6% with PGA2, 3% with PGA1, 1.3% with
P G F 2, and less than 1% cross-reactivity with other related
eicosanoids at 50% bound/total (42). However, it has been shown
using gas chromatography-mass spectroscopy that 970/0 of PGE
production by human monocytes in response to bacterial LPS is PGE2
(25, 42). In addition, LPS-treated monocytes release relatively
small amounts of eicosanoid products capable of cross-reacting in
the PGE radioimmunoassay (41). Furthermore, the anti-TxB2
antibody demonstrates no significant cross-reactivity (less than
0.1 %) with any of the aforementioned products. Finally, the IL-1 p
antiserum used in the IL-1 ~ radioimmunoassay is specific for IL-1 p
and exhibits no cross-reactivity with IL-1 a, IL-2, TNF or 1-1 F N
(Cistron technical bulletin). Therefore, based on this information,
the PGE, TxB2 and IL-1 p radioimmunoassays were considered
acceptable to quantitate the release of immunoreactive PGE2, TxB2
and IL-1 (3.
The use of Percoll density centrifugation resulted in reduced
cell yield and higher control eicosanoid release when compared to
the elutriator fractions. Because the cell yield was limited, DNA
corrections at 8 hours and determinations of mean fluorescence
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intensity at 0 and 8 hours could not be determined in every
experiment. However, for those experiments when there was enough
cellular material, the ratio of DNA remaining between fractions 2 or
3 and fraction 1 at 8 hours was virtually th.e same as the ratio at 24
hours. In addition, the mean fluorescence intensity did not differ
significantly between fractions at eight hours and monocytes from
all three fractions expressed barely detectable levels of the M03e
antigen at time zero.
Previous studies (16,25,56) have demonstrated that higher
density monocytes produce greater amounts of PGE2 and IL-1. Our
lowest density fraction corresponded to the same specific gravity
and represented the same percentage of total monocytes as the
lowest density fraction described by Tice et al. (56). However,
because Fraction 1 never entered the gradient and only half as much
DNA was retained in its culture wells at 24 hours than in the other
two fractions, it is· likely that this fraction represented a damaged
cell popu lation. Furthermore, the nonadherent cells (cells which
were not retained in the culture wells), although positive for Leu-
M3, did not produce appreciable amounts of TxB2, PGE2, or IL-1 ~ at
any time point.
Consistent with previous reports, M03e expression on the
monocyte cell surface was significantly increased with exposure to
LPS for both Percoll-isolated and counterflow-isolated subsets (35,
59). Indeed, M03e was not expressed on the cell surface at 0 hours
and an increase in its expression was seen after an 8 and 24 hour
exposure to LPS for all subsets, although monocytes in LPS-free
medium for 24 hours did not demonstrate cell surface Mo3e
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expression. Mo3e antigen expression was even higher after 48 and
72 hours of LPS exposure; however, PGE2 and TxB2 release between
24 and 72 hours in culture was not significantly higher than control
levels (23). Leu-M3 expression also increased after a 24 hour
exposure to LPS, although there was actually a diminution in mean
fluorescence intensity at 8 hours, which suggests shedding or
internalization of the Leu-M3 antigen between 0 and 8 hours.
Although both Leu-M3 and M03e expression differed markedly
between a and 24 hours, no significant differences in Leu-M3 or
Mo3e expression were observed between subpopulations isolated by
either Percoll density centrifugation or counterflow centrifug"al
elutriation at any time point.
This study reveals no human monocyte subpopulation primarily
responsible for PGE2, TxB2 or IL-1{3 release. Such subpopulations
may exist, but current mea~s of separating monocytes into
subpopulations based on density and/or size did not allow for subset
detection. Our inability to define distinct monocyte subpopulations
is in agreement with a recent study by Dransfield at al. (15).
However, the results of this experiment suggest that the
independent synthesis of TxB2 and PGE2 observed in our laboratory
may be due to distinct metabolic processes within a single
population of monocytes and not due to the existence of discrete
subpopulations. Differential relea'se of immunoreactive TxB2 and
PG E2 could result from independent activities of the thromboxane
synthetase and prostaglandin isomerase enzymes, but the disparate
- specific activities cannot be explained in this way. Differentially
labeled arachidonic acid pools and independent cyclooxygenase
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metabolic compartments within a single subset of cells may be
responsible for the differential specific activities of TxB2 and PGE2
released from LPS-activated monocytes. Confirmation of the
divergent specific activities of PGE2 and TxB2 by gas
chromatography-mass spectroscopy and exploration of the
possibility of independent cyclooxygenase metabolic compartments
will be the focus of future studies. Finally, the data in this study
suggest that the PGE2 hypersecretory response observed in patients
with severe periodontitis (24) and in patients with Hodgkin's
disease (17,27) may reflect hypersecretion of the entire monocyte
population rather than only a particular subset.
THESIS DISCUSSION
This investigation demonstrated that Percoll-isolated and
counterflow-isolated monocyte subpopulations do not differ with
respect to PGE2, TxB2 and IL-1 ~ release or Leu-M3 and Mo3e surface
antigen expression. In the majority of previous studies, adherence
was used to enrich mononuclear cell preparations for monocytes. It
is possible that this isolation technique coupled with the physical
removal of monocytes from plastic culture wells prior to assessing
functional activity activated the whole monocyte population, and
possibly some monocytes more than others. This phenomenon is
likely since some monocytes are more adherent and, therefore, may
be activated by the scraping procedure to a greater extent than less
adherent monocytes. Furthermore, in each of these studies,
monocyte purity was assessed by nonspecific esterase staining,
morphology or phagocytosis of latex particles. Immunofluorescence
was not used to confirm minimal contamination of monocyte
cultures with lymphocytes and other peripheral blood elements and
immunofluorescence was not used to confirm monocyte identity.
However, a number of these studies were conducted before the
availability of Leu-M3 and other monoclonal reagants that could have
confirmed monocyte purity. Because countercurrent centrifugal
elutriation was used in our experimental protocol to enrich
mononuclear cell preparations for monocytes and the elutriation
process was monitored by electronic sizing, the cells placed in
culture in this study were virtually all monocytes. In previous
investigations, monocytes were cultured in RPMI 1640 medium at
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37°C for one hour with, in all likelihood, a fourfold excess of
lymphocytes. Lymphokines elaborated by the lymphocytes may have
played a role in the activation of monocytes in culture.
Interestingly, in the majority of previous investigations, the
functional properties of monocytes in unstimulated cultures were
not mentioned.
The differential specific activities of PGE2 and TxB2 may be
accounted for by compartmentalization of cyclooxygenase enzymes
and differentially labeled arachidonic acid pools. However,
compartmentalization of cyclooxygenase enzymes has never been
demonstrated. The PGE2 and TxB2 specific activity differences will
first be confirmed by gas chromatography-mass spectroscopy (GC-
MS) before exploring this possibility, since GC-MS represents the
best method for specific estimation of nanogram quantities of
prostanoids in the presence of interfering substances.
The patterns of immunoreactive TxB2 and IL-1 J3 release are
similar over the 24 hour time course. In addition, between 24 and
72 hours, their release continues to decline and actually equals
control levels. However, although peak release for PGE2 also occurs
during the 2-8 hour interval, another rise in PGE2 release occurs
during the 16-24 hour interval following a decline between 8 and 16
hours. It has been shown that IL-1 can regulate its own production
through PGE2, a self-induced inhibitor (34). IL-1 alone can elevate
endogenous PGE2 levels and the dose-dependent suppressive effect
of exogenous PGE2 on IL-1 production by LPS-stimulated monocytes
has been demonstrated (34). These phenomena may be responsible
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for the dimunition in IL-1 ~ release after 8 hours and the increase in
PG E2 release during the 16-24 hour interval.
Percoll and countercurrent centrifugal elutriation are accepted
techniques for separating monocytes into subpopulations, although
such separation may be artifactual. This investigation represents
the first report in which both techniques were used to fractionate
monocytes into subpopulations and in which elutriation was used to
isolate monocytes from mononuclear cells prior to Percoll density
centrifugation. Even though both techniques resulted in monocyte
subpopulations that differed with respect to relative cell size, no
functional or phenotypic heterogeneity was noted between subsets.
Cell sorting on the basis of cell size and shape may represent
another technique that can be used to evaluate potential monocyte
heterogeneity, but this method has several limitations that may
preclude its implementation. First, 10-900/0 of the counterflow-
isolated monocytes may be lost during cell sorting (31). Second,
monocytes may be activated by this technique. Third, since the cell
sorter can only process 107 cells per hour, it would take
approximately five hours to sort an average donor's monocytes (31).
Cells isolated at one hour may differ functionally from those
isolated at the termination of cell sorting, merely because of the
long isolation procedure.
It has been noted that inter-individual differences with
respect to PGE2 secretion by LPS-stimulated human monocytes far
exceed the intra-individual differences observed for replicate blood
donations up to six months apart (40, 43). This phenomenon needs to
be explored more carefully, particularly since it appears that high
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and low responders to LPS may exist, using PGE2 release as the
marker of LPS-responsiveness (17,24). In addition, it would be
worthwhile to investigate relative expression of activation-
associated antigens on the cell surface of human peripheral blood
monocytes in different donors to determine if 1) differences exist
between healthy individuals and 2) immunophenotypes remain stable
over time. It has been reported that immunophenotypes of healthy
individuals examined on a weekly basis for 13 weeks differed less
than 5% between donations with respect to T4 and T8 antigen
expression (7).
Heterogeneity certainly exists among fluid macrophages. The
multitude of functions that these macrophages perform coupled with
the evidence for restriction of cell surface markers to macrophages
of defined anatomical locations confirms this fact. Whether or not
such heterogeneity is evident in human peripheral blood monocytes
is still uncertain. Although our investigation did not reveal any
differences between subpopulations with respect to PGE2, TxB2 0 r
I L-1 f3 release, numerous other monocyte functions such as Fe
receptor-mediated activity, la expression, and phagocytosis need to
be re-examined using counterflow-isolated monocytes, to assess
whether these functional activities differ among subpopulations or
whether previous investigations yielded artifactual differences. In
addition, further studies should be carried out to compare
expression of differentiation antigens on bone marrow precursors,
blood monocytes and tissue and fluid phase macrophages. Hancock at
al. have already shown that PHM3 labels a differentiation antigen
expressed on monocytes only after entry into the circulation (29).
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This antigen appears to be restricted in its distribution to
circulating monocytes, as it is present only at very low antigen
densities on peritoneal macrophages and Kupffer cells. Furthermore,
FMC17 appears to be organ selective since its expression is confined
to alveolar macrophages (29). Relationships between bone marrow
precursor cells, monocytes, macrophages and other hematopoietic
elements can only be elucidated by further studies which
characterize the cell surface differentiation antigens of the
mononuclear phagocyte system. In addition, studies which correlate
functional activities that are restricted to certain tissue sites or
fluids with the presence of particular cell surface antigens will
enable investigators to determine whether peripheral blood
monocytes are a homogeneous, multipotent population or whether
discrete monocyte subsets exist with predetermined capabilities to
differentiate into specific tissue or fluid macrophages.
Table 1. PG E2, TxB2 and IL-1 ~ Release from Percoll-Isolated
Monocyte Fractions After DNA Correction
Fraction # PGE2 TxB2 IL-1 f3
1 (Control) 0.25 O.12±O.11 O.O1±O.O1
1 (LPS) O.32±O.O7 O.95±O.30 O.O2±O.01
2 (Control) 0.O4±O.O4 O.O6±O.O4 0
2 (LPS) O.47±O.12 1.32±O.38 O.O4±O.O2
3 (Control) O.O6±O.O5 O.12±O.O8 O.O1±O.O1
3 (LPS) O.60±O.22 1.25±O.33 O.O5±O.O4
All values for PGE2 and TxB2 represent the mean (ng eicosanoid/Jlg
DNA) ±. standard error for the 16-24 hour time interval for six
determinations except PGE2 for fraction 1 control, which only
represents one determination, ~ince the control release from the
other culture wells was zero. All values for IL-1 J3 represent the
mean ±. standard error for three determinations
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Table 2. PG E2, TxB2 and IL-1 ~ Release from Counterflow-Isolated
Monocyte Fractions After DNA Correction
Fraction # PGE2 TxB2 IL-1 ~
Small (Control) 0 0 0
Small (LPS) 0.48±0.18 0.70±O.14 O.O8±O.O6
Medium (Control) 0 0 0
Medium (LPS) 0.45+0.15 O.70±0.17 O.O7±0.O7
Large (Control) 0 0 0
Large (LPS) O.49±O.25 0.71±O.22 O.O4±O.O2
All values for PG E2 and TxB2 represent the mean (ng eicosanoid/J.lg
DNA) ±. standard error for the 16-24 hour time interval for six
determinations. All values for IL-1 ~ represent the mean ± standard
error for three determinations
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Table 3. Leu-M3 and Me3e Antigen Expression on Percoll-Isolated
Monocyte Subpepulations at 24 Hours
FRACTION
Fi rst
Second
Third
Leu-M3
324.96±.71.52
293.44:±.20.55
348.48
Mo3e
398.39±11 .1 a
351.26±.34.16
289.83±45.62
All values represent the mean fluorescence intensity ±. standard
error for monocytes isolated from three different donors except for
Leu-M3 expression on the third fraction which represents one
determination. The mean fluorescence intensity for the irrelevant
IgG2b murine monoclonal antibody (MOPC 141) was 18.43, while the
mean fluorescence intensity for the irrelevant IgM murine
monoclonal antibody (TEPC 183) was 15.45.
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Table 4. Mo3e Antigen Expression on Counterflow-Isolated
Monocyte Subpopulations
FRACTION
Small
Medium
Large
QHOUR
16.26±.3.18
16.62±.3.15
17.42±.3.29
8 HOUR
136.88±10.88
141.69±15.62
142.20±.25.70
24 HOUR
261.21±13.42
275.30±22.25
285.54±.40 .89
All values represent the mean fluorescence intensity ±. standard
error for monocytes isolated from three diferent donors. The mean
fluorescence intensity for the irrelevant IgM murine monoclonal
antibody (TEPC 183) was 10.19.
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Table 5. Leu-M3 Antigen Expression on Counterflow-Isolated
Monocyte Subpopulations
FRACTION
Small
Medium
Large
OHQUR
137.07±8.76
133.81±5.85
139.41±4.80
8HQUR
100.98±12.97
96.74±11.79
99.85±11.50
24 HOUR
225.75±12.14
232.61±17.48
230.95±18.15
All values represent the mean fluorescence intensity ±. standard
error for monocytes isolated from three different donors. The
mean fluorescence intensity for the irrelevant IgG2b murine
monoclonal antibody (MOPC 141) was 22.40.
Figure 1. Fraction 1 represents the monocyte subpopulation
harvested at the density interface between 10 and 40% Percoll,
Fraction 2 represents the monocyte subpopulation obtained from the
density interface between 40 and 45% Percoll, and Fraction 3
represents the monocyte subpopulation harvested at the density
interface between 45 and 50% Percoll.
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Figure 2. Fraction 1 represents the first monocyte subpopulation
(small monocytes) to elute from the Sanderson chamber. Fractio.n 2
represents the second monocyte subpopulation to elute (medium-
sized monocytes). Fraction 3 represents the last monocyte
subpopulation to elute (large monocytes) after turning off the rotor.
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Figure 3. Time course of PGE2 release from human peripheral blood
monocytes that were fractionated into subpopulations by
discontinuous Percoll density gradients. Monocytes were cultured
with either control medium or LPS-containing medium (10 JJ,g/m I
Salmonella typhimurium LPS). All values represent the mean ±
standard error for PGE2 release from six different donors.
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Figure 4. Time course of TxB2 release from human peripheral blood
monocytes that were fractionated into subpopulations by
discontinuous Percell d~nsity gradients. Menecytes were cultured
with either control medium or LPS-containing medium (10 J,!g/m I
Salmonella typhimurium LPS). All values represent the mean ±.
standard error for TxB2 release from six different donors.
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Figure 5. Time course of IL-1 ~ release from human peripheral blood
monocytes that were fractionated into subpopulations by
discontinuous Percoll density gradients. Monocytes were cultured
with either control medium or LPS-containing medium (10 Jlg/m I
Salmonella typhimurium LPS). All values represent the mean ±.
standard error for IL-1 f3 release from three different donors.
87
6
5
4
ng/ml
3
2
o
55
IL-l~ Release From Percoll Fractions
• First, Control
II First, LPS
II Second, Control
~ Second, LPS
o Third, Control
II Third, LPS
0-2 h 2-8 h
Interval
8-16 h 16-24 h
56
Figure 6. Time course of PGE2 release from human peripheral blood
monocytes that were fractionated into subpopulations by
counterflow centrifugal elutriation. Monocytes were cultured with
either control medium or LPS-containing medium (1 0 IJ,g / m I
Salmonella typhimurium LPS). All values represent the mean +
standard error for PGE2 release from six different donors.
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Figure 7. Time course of TxB2 release from human peripheral blood
monocytes that were fractionated into subpopulations by
counterflow centrifugal elutriation. Monocytes were cultured with
either control medium or LPS-containing medium (1 0 Jlg / m I
Salmonella typhimurium LPS). All values represent the mean ±.
standard error for TxB2 release from six different donors.
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Figure 8. Time course of IL-1 ~ release from human peripheral blood
monocytes that were fractionated into subpopulations by
counterflow centrifugal elutriation. Monocytes were cultured with
either control medium or LPS-containing medium (10 Ilg / m I
Salmonella typhimurium LPS). All values represent the mean +
standard error for IL-1 ~ release from three different donors.
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Figure 9. Time course of [3H] PG E2 release from LPS-treated human
monocytes fractionated into subpopulations by countercurrent
centrifugal elutriation. Monocytes were cultured with medium
containing 0.1 ~Ci/ml [3H]arachidonic acid for two hours during the
period of cell adherence after which the cells were washed twice
with unlabeled medium. Monocytes were then cultured in LPS-
containing medium (1 0 JJ.g/ml Salmonella typhimurium LPS) for 24
hours without label, with media exchanges at 2, 8, 16 and 24 hours.
Each determination represents labeled eicosanoid extracted from
replicate (four) pooled culture supernatants. Histogram bars
represent the mean ± standard error for [3H] PG E2 release from three
different donors.
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Figure 10. Time course of [3H]TxB2 release from LPS-treated human
monocytes fractionated into subpopulations by countercurrent
centrifugal elutriation. Monocytes were cultured with medium
containing 0.1 JlCi/ml [3H]arachidonic acid for two hours during the
period of cell adherence after which the cells were washed twice
with unlabeled medium. Monocytes were then cultured in LPS-
containing medium (1 0 Jlg/ml Salmonella typhimurium LPS) for 24
hours without label, with media exchanges at 2, 8, 16 and 24 hours.
Each determination represents labeled eicosanoid extracted from
replicate (four) pooled culture supernatants. Histogram bars
represent the mean ±. standard error for [3H]TxB2 release from three
different donors.
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Figure 11. Time course of [3H] PG E2 release from LPS-treated human
monocytes fractionated into subpopulations by countercurrent
centrifugal elutriation. Monocytes were cultured with medium
containing 0.1 JlCi/ml [3H]arachidonic acid during the two hour cell
adherence period. Monocytes were washed twice with unlabeled
medium and then treated with 10 J.1g/ml Salmonella typhimurium
LPS plus 0.1 JlCi/ml [3H]arachidonic acid. Medium was exchanged at
2, 8, 16, and 24 hours and replaced with identical medium. Each
determination represents labeled eicosanoid extracted from
replicate (four) pooled culture supernatants. Histogram bars
represent the mean ± standard error for [3H] PG E2 release from three
different donors.
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Figure 12. Time course of [3H]TxB2 release from LPS-treated human
monocytes fractionated into subpopulations by countercurrent
centrifugal elutriation. Monocytes were cultured with medium
containing 0.1 JlCi/ml [3H]arachidonic acid during the two hour cell
adherence period. Monocytes were washed twice with unlabeled
medium and then treated with 10 J.19/ml Salmonella typhimurium
LPS plus 0.1 J.lCi/ml [3H]arachidonic acid. Medium ·was exchanged at
2, 8, 16, and 24 hours and replaced with identical' medium. Each
determination represents labeled eicosanoid extracted from
replicate (four) pooled culture supernatants. Histogram bars
represent the mean ± standard error for [3H]TxB2 release from three
different donors.
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Figure 13. Light-Scattering and FACS Profiles of Monocyte
Preparations (a, b, c)
(a) Representative light-scattering profile of a monocyte
subpopulation isolated by Percoll density centrifugation.
(b) Representative FACS profile of a Percoll-isolated monocyte
subpopulation stained with a negative control IgM monoclonal
antibody by indirect immunofluorescence after a 24 hour incubation
with Salmonella typhimurium LPS (10 Jlg/ml).
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(c) Representative FACS profile of a Percoll-isolated monocyte
subpopulation stained with anti-Mo3e by indirect
.immunofluorescence after a 24 hour incubation with Salmonella
typhimurium LPS (10 )lg/ml).
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